Europe - Frankfurt Stock Exchange - FRA:ZEG - GB0009895292 - Common Stock
Overall ZEG gets a fundamental rating of 5 out of 10. We evaluated ZEG against 55 industry peers in the Pharmaceuticals industry. While ZEG has a great profitability rating, there are some minor concerns on its financial health. ZEG is valied quite expensively at the moment, while it does show a decent growth rate.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.21% | ||
| ROE | 20.48% | ||
| ROIC | 14.42% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 24.34% | ||
| PM (TTM) | 16.17% | ||
| GM | 81.9% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.61 | ||
| Debt/FCF | 3.41 | ||
| Altman-Z | 6.08 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.88 | ||
| Quick Ratio | 0.69 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.42 | ||
| Fwd PE | 17.64 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 60.38 | ||
| EV/EBITDA | 29.12 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.8% |
ChartMill assigns a fundamental rating of 5 / 10 to ZEG.DE.
ChartMill assigns a valuation rating of 3 / 10 to ASTRAZENECA PLC (ZEG.DE). This can be considered as Overvalued.
ASTRAZENECA PLC (ZEG.DE) has a profitability rating of 7 / 10.
The Price/Earnings (PE) ratio for ASTRAZENECA PLC (ZEG.DE) is 20.42 and the Price/Book (PB) ratio is 12.59.
The Earnings per Share (EPS) of ASTRAZENECA PLC (ZEG.DE) is expected to grow by 14.52% in the next year.